Your browser doesn't support javascript.
loading
Safe eradication of large established tumors using neovasculature-targeted tumor necrosis factor-based therapies.
Huyghe, Leander; Van Parys, Alexander; Cauwels, Anje; Van Lint, Sandra; De Munter, Stijn; Bultinck, Jennyfer; Zabeau, Lennart; Hostens, Jeroen; Goethals, An; Vanderroost, Nele; Verhee, Annick; Uzé, Gilles; Kley, Niko; Peelman, Frank; Vandekerckhove, Bart; Brouckaert, Peter; Tavernier, Jan.
Afiliación
  • Huyghe L; Cytokine Receptor Laboratory, VIB Center for Medical Biotechnology, Department of Biomolecular Medicine, Ghent University, Ghent, Belgium.
  • Van Parys A; Cytokine Receptor Laboratory, VIB Center for Medical Biotechnology, Department of Biomolecular Medicine, Ghent University, Ghent, Belgium.
  • Cauwels A; Cytokine Receptor Laboratory, VIB Center for Medical Biotechnology, Department of Biomolecular Medicine, Ghent University, Ghent, Belgium.
  • Van Lint S; Cytokine Receptor Laboratory, VIB Center for Medical Biotechnology, Department of Biomolecular Medicine, Ghent University, Ghent, Belgium.
  • De Munter S; Department of Clinical Chemistry, Microbiology and Immunology, Ghent University, Ghent, Belgium.
  • Bultinck J; Cytokine Receptor Laboratory, VIB Center for Medical Biotechnology, Department of Biomolecular Medicine, Ghent University, Ghent, Belgium.
  • Zabeau L; Orionis Biosciences, Boston, MA, USA.
  • Hostens J; Department of Biomedical Molecular Biology, Ghent University, Ghent, Belgium.
  • Goethals A; Department of Biomedical Molecular Biology, Ghent University, Ghent, Belgium.
  • Vanderroost N; Cytokine Receptor Laboratory, VIB Center for Medical Biotechnology, Department of Biomolecular Medicine, Ghent University, Ghent, Belgium.
  • Verhee A; Cytokine Receptor Laboratory, VIB Center for Medical Biotechnology, Department of Biomolecular Medicine, Ghent University, Ghent, Belgium.
  • Uzé G; CNRS UMR 5235, University of Montpellier, Montpellier, France.
  • Kley N; Orionis Biosciences, Boston, MA, USA.
  • Peelman F; VIB Center for Medical Biotechnology, Department of Biomolecular Medicine, Ghent University, Ghent, Belgium.
  • Vandekerckhove B; Department of Clinical Chemistry, Microbiology and Immunology, Ghent University, Ghent, Belgium.
  • Brouckaert P; Department of Biomedical Molecular Biology, Ghent University, Ghent, Belgium.
  • Tavernier J; Cytokine Receptor Laboratory, VIB Center for Medical Biotechnology, Department of Biomolecular Medicine, Ghent University, Ghent, Belgium.
EMBO Mol Med ; 12(2): e11223, 2020 02 07.
Article en En | MEDLINE | ID: mdl-31912630
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Factor de Necrosis Tumoral alfa / Inmunoterapia / Neoplasias Límite: Animals Idioma: En Revista: EMBO Mol Med Asunto de la revista: BIOLOGIA MOLECULAR Año: 2020 Tipo del documento: Article País de afiliación: Bélgica Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Factor de Necrosis Tumoral alfa / Inmunoterapia / Neoplasias Límite: Animals Idioma: En Revista: EMBO Mol Med Asunto de la revista: BIOLOGIA MOLECULAR Año: 2020 Tipo del documento: Article País de afiliación: Bélgica Pais de publicación: Reino Unido